(R)-desmethylsibutramine

R-去甲基西布曲明

Report date: 2022/03/09 15:08:50
NME

Base Information

Drug Name(R)-desmethylsibutramine
Drug Alias NameR-DidesmethylsibutramineR-sibutramine metabolite(+)-DidesmethylsibutramineR-DesmethylsibutramineR-Desmethyl Sibutramine +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsDopamine transporter antagonistsNorepinephrine transporter inhibitors
TargetsSerotonin transporterDopamine transporterNorepinephrine transporter
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSunovion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A